{"id":"https://openalex.org/W2979589359","doi":"https://doi.org/10.1182/blood.v128.22.4694.4694","title":"Feasibility of Allogeneic Hematopoietic Stem Cell Transplant for High Risk FLT3-ITD Mutant Patients with Acute Myeloid Leukemia in CR1- a Real Word Analysis","display_name":"Feasibility of Allogeneic Hematopoietic Stem Cell Transplant for High Risk FLT3-ITD Mutant Patients with Acute Myeloid Leukemia in CR1- a Real Word Analysis","publication_year":2016,"publication_date":"2016-12-02","ids":{"openalex":"https://openalex.org/W2979589359","doi":"https://doi.org/10.1182/blood.v128.22.4694.4694","mag":"2979589359"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v128.22.4694.4694","doi":"https://doi.org/10.1182/blood.v128.22.4694.4694","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.4694.4694","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027546805","display_name":"Ankit J. Kansagra","orcid":"https://orcid.org/0000-0001-6901-0782","observed_orcids":["https://orcid.org/0000-0001-6901-0782"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ankit J. Kansagra","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064856519","display_name":"Hassan B. Alkhateeb","orcid":"https://orcid.org/0000-0002-3609-8404","observed_orcids":["https://orcid.org/0000-0002-3609-8404"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hassan B Alkhateeb","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067492340","display_name":"Mehrdad Hefazi","orcid":"https://orcid.org/0000-0001-8860-3380","observed_orcids":["https://orcid.org/0000-0001-8860-3380"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mehrdad Hefazi","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012781424","display_name":"Fevzi Yalniz","orcid":"https://orcid.org/0000-0003-3569-8632","observed_orcids":["https://orcid.org/0000-0003-3569-8632"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Fevzi Yalniz","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084606047","display_name":"William J. Hogan","orcid":"https://orcid.org/0000-0002-5841-4105","observed_orcids":["https://orcid.org/0000-0002-5841-4105"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William J Hogan","raw_affiliation_strings":["Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark R Litzow","raw_affiliation_strings":["Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Blood and Marrow Transplantation Program, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072463255","display_name":"Mrinal M. Patnaik","orcid":"https://orcid.org/0000-0001-6998-662X","observed_orcids":["https://orcid.org/0000-0001-6998-662X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mrinal M Patnaik","raw_affiliation_strings":["Division of Hematology, Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1330342723"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.3168,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.72881909,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"128","issue":"22","first_page":"4694","last_page":"4694"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9390000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.9390000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.056699998676776886,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9390000104904175},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.8849999904632568},{"id":"https://openalex.org/keywords/flt3-itd-mutation","display_name":"FLT3-ITD","score":0.9800000190734863},{"id":"https://openalex.org/keywords/first-complete-remission","display_name":"first complete remission","score":0.8889999985694885},{"id":"https://openalex.org/keywords/flt3-inhibitors","display_name":"FLT3 inhibitors","score":0.5580000281333923},{"id":"https://openalex.org/keywords/consolidation-therapy","display_name":"consolidation therapy","score":0.5199999809265137},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.5139999985694885},{"id":"https://openalex.org/keywords/relapse-free-survival","display_name":"relapse-free survival","score":0.47999998927116394},{"id":"https://openalex.org/keywords/cytogenetically-normal-aml","display_name":"cytogenetically normal AML","score":0.7369999885559082},{"id":"https://openalex.org/keywords/real-world-outcomes","display_name":"real-world outcomes","score":0.6589999794960022},{"id":"https://openalex.org/keywords/post-remission-therapy","display_name":"post-remission therapy","score":0.492000013589859}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8104379177093506},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6479239463806152},{"id":"https://openalex.org/C2778041864","wikidata":"https://www.wikidata.org/wiki/Q180983","display_name":"Cytarabine","level":3,"score":0.612655758857727},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5947130918502808},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.5870558619499207},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.5677880048751831},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4770090579986572},{"id":"https://openalex.org/C88879693","wikidata":"https://www.wikidata.org/wiki/Q217690","display_name":"Cumulative incidence","level":3,"score":0.44646573066711426},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.4129261374473572},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.4119781255722046},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3340756297111511},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.07259529829025269},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v128.22.4694.4694","doi":"https://doi.org/10.1182/blood.v128.22.4694.4694","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v128.22.4694.4694","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2567632428","https://openalex.org/W4395053589","https://openalex.org/W7127363738","https://openalex.org/W1990135782","https://openalex.org/W2586519274","https://openalex.org/W3185347845","https://openalex.org/W2967180135","https://openalex.org/W2936947001","https://openalex.org/W2984822525","https://openalex.org/W2199445282"],"abstract_inverted_index":{"Background:":[0],"Hematopoietic":[1],"stem":[2],"cell":[3],"transplantation":[4],"(HCT)":[5],"remains":[6],"the":[7,99,159,215,238,273,339,375],"most":[8,285],"effective":[9,329],"postremission":[10],"therapy":[11],"for":[12,78,91,98,142,292,309,332,384],"high-risk":[13],"acute":[14],"myeloid":[15],"leukemia":[16],"(AML).":[17],"FMS-like":[18],"tyrosine":[19],"kinase3":[20],"(FLT3)":[21],"mutations":[22,37],"occur":[23],"in":[24,55,76,119,158,267,282,294,338,348,353,361,369],"about":[25],"30%":[26],"of":[27,73,112,166,214,228,237,250,261,377,399],"patients":[28,93,109,134,155,205,216,240,263,277,320],"with":[29,40,162,191,222,247],"cytogenetically":[30],"normal":[31,186],"AML.":[32],"FLT3-ITD":[33,79],"(internal":[34],"tandem":[35],"duplications)":[36],"are":[38,345,381],"associated":[39],"short-lived":[41],"remissions":[42],"and":[43,138,147,356,374],"poor":[44],"outcomes.":[45],"These":[46],"adverse":[47],"effects":[48],"can":[49],"be":[50],"offset":[51],"by":[52],"allogeneic":[53,74,117,257,325],"HCT":[54,75,118,281,293,310,326],"first":[56],"complete":[57],"remission":[58],"(CR1).":[59],"We":[60,270],"carried":[61],"out":[62,260],"this":[63],"study":[64],"to":[65,105,177,208,226,243,312,351,366,401],"get":[66],"a":[67,163,201,220,223,245,342],"real":[68,340],"world":[69],"perspective":[70],"on":[71,200,207],"feasibility":[72],"CR1":[77,349],"mutant":[80,335],"AML":[81,87,336],"patients.":[82,386],"Methods:":[83],"The":[84,284],"Mayo":[85],"Clinic":[86],"database":[88],"was":[89,181],"queried":[90],"all":[92],"that":[94,301],"had":[95,136,185,299],"tested":[96],"positive":[97],"FLT3":[100,265,333],"ITD,":[101],"from":[102,129,175],"January":[103],"2003":[104],"December":[106],"2014.":[107],"75":[108],"were":[110,122,126,140,150,156,198,241,306,321],"identified,":[111],"which":[113,251],"28":[114],"(37%)":[115],"underwent":[116,256],"CR1.":[120,283],"12":[121],"excluded":[123,141],"as":[124],"they":[125],"transplant":[127,357],"ineligible":[128],"an":[130,328],"age":[131,165],"standpoint,":[132],"6":[133,252],"actually":[135],"MDS":[137],"2":[139,392],"primary":[143],"induction":[144],"failure.":[145],"Clinical":[146],"outcomes":[148],"data":[149],"abstracted":[151],"retrospectively.":[152],"Results:":[153],"29":[154],"included":[157],"final":[160],"analysis,":[161],"median":[164,224],"57":[167],"years":[168],"(range":[169,231],"21-68),":[170],"38%":[171],"males.":[172],"Median":[173],"time":[174,225],"diagnosis":[176],"last":[178,316],"follow":[179,317],"up":[180,291,318],"339":[182],"days.":[183],"24(83%)":[184],"cytogenetics.":[187],"26(90%)":[188],"received":[189,264],"treatment":[190],"anthracycline":[192],"+":[193],"cytarabine":[194],"based":[195],"therapy,":[196],"3(10%)":[197],"enrolled":[199],"clinical":[202],"trial.":[203],"25(87%)":[204],"went":[206],"receive":[209],"consolidation":[210],"therapy.":[211],"22":[212,239],"(75%)":[213],"relapsed":[217,276],"after":[218],"achieving":[219],"CR1,":[221],"relapse":[227,288],"134":[229],"days":[230],"27-1710":[232],"days).":[233],"Only":[234],"8":[235,262],"(26%)":[236],"able":[242],"achieve":[244],"CR2":[246],"salvage":[248],"chemotherapy,":[249],"(75":[253],"%)":[254],"successfully":[255],"HCT.2":[258],"(25%)":[259],"inhibitor":[266],"1st":[268],"relapse.":[269,363],"then":[271],"assessed":[272],"reasons":[274],"why":[275],"did":[278],"not":[279,346],"undergo":[280],"common":[286],"being;":[287],"during":[289],"evaluation/work":[290],"8(27%)":[295],"patients,":[296,337],"5":[297],"(17%)":[298],"comorbidities":[300],"precluded":[302],"HCT,":[303],"3":[304],"(10%)":[305],"never":[307],"referred":[308],"due":[311,350],"personal":[313],"preferences.":[314],"At":[315],"19(65%)":[319],"dead.":[322],"Conclusion:":[323],"While":[324],"is":[327],"consolidative":[330],"strategy":[331],"ITD":[334],"world,":[341],"large":[343],"number":[344],"transplanted":[347],"delays":[352,368],"donor":[354,372,379],"search":[355],"scheduling":[358],"strategies":[359,365],"resulting":[360],"disease":[362],"Effective":[364],"avoid":[367],"scheduling,":[370],"rapid":[371],"searches":[373],"use":[376],"alternative":[378],"sources":[380],"much":[382],"needed":[383],"these":[385],"Figure":[387,389,391,393],"1":[388],"1.":[390],"2.":[394],"Disclosures":[395],"No":[396],"relevant":[397],"conflicts":[398],"interest":[400],"declare.":[402]},"counts_by_year":[{"year":2017,"cited_by_count":1}],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2019-10-18T00:00:00"}